CPT only copyright 2011 American Medical Association. Page 2 of 5 What You Need to Know This article explains the difference between a National Provider Identifier (NPI) and a Provider Transaction Access Number (PTAN). There are no policy changes in this article.
For people with aggressive B cell non-Hodgkin lymphoma, we commonly recommend a chemotherapy treatment called R-CHOP. It is named after the medicines included in the mixture: rituximab (RituxanÂ®), a monoclonal antibody that helps your immune system destroy the cancer cells and makes the chemotherapy more powerful
Monoclonal antibodies in the treatment of non-Hodgkin's lymphoma. Fanale MA, Younes A. Antibody-based therapeutic approaches have had a significant impact in the treatment of non-Hodgkin's lymphoma (NHL).Rituximab's development as an anti-CD20 antibody heralded a new era in treatment approaches for NHL.ntibody-based therapeutic approaches have had a significant impact in the treatment of non-Hodgkin's lymphoma (NHL).